Table of Contents
Buy High-Purity TBK1 Inhibitor for Cutting-Edge Research – 99%+ Purity, GMP Certified
Struggling with unreliable TBK1 inhibitors that compromise your innate immunity and oncology studies? As a corporate purchasing manager, get research-grade TBK1 inhibitor with full compliance, fast USA delivery, and 30% cost savings versus competitors.
Or call +86 19943830844 | Email: service@huanqiukeji9.com
In the fast-evolving landscape of biomedical research projected into 2026, TBK1 inhibitors stand as pivotal tools for dissecting complex signaling pathways. TBK1, or TANK-Binding Kinase 1, is a non-canonical IκB kinase (IKK) family member that plays a central role in innate immune responses. Discovered in the late 1990s, TBK1 phosphorylates interferon regulatory factor 3 (IRF3), triggering type I interferon production essential for antiviral defense. But its influence extends far beyond immunity—TBK1 regulates autophagy, NF-κB signaling, and mitotic spindle orientation, making it a prime target in oncology, neurodegeneration, and inflammatory diseases.
Structurally, TBK1 features an N-terminal kinase domain, a central scaffold/dimerization domain, and a C-terminal ubiquitin-binding domain. Its activation involves K63-linked polyubiquitination and dimerization, often triggered by upstream sensors like STING or RIG-I in response to cytosolic DNA or viral RNA. In cancer research, TBK1 hyperactivation promotes tumor survival via RAS pathway crosstalk, positioning TBK1 inhibitors as promising adjuvants in immunotherapy. For instance, studies from 2020-2025 (pre-2026 projections) show TBK1 inhibition sensitizes KRAS-mutant lung cancers to PD-1 blockers, with preclinical data indicating 65% tumor regression in mouse models (Nature Reviews Cancer, 2023).
In neurodegeneration, TBK1 mutations are implicated in ALS/FTD syndromes, where loss-of-function variants disrupt selective autophagy of protein aggregates like TDP-43. High-purity TBK1 inhibitors enable precise interrogation of these mechanisms, revealing therapeutic windows for mitophagy enhancers. By 2026, with AI-driven drug discovery accelerating, demand for reliable TBK1 inhibitors surges among pharma R&D teams, as they bridge basic science to clinical translation.
Chemically, potent TBK1 inhibitors like BX-795 (IC50 ~6 nM) covalently target the ATP-binding pocket, while allosteric modulators like Compound 18 disrupt dimerization. Our TBK1 inhibitor offerings at Global Technology Co., Ltd exceed 99% HPLC purity, DMF-compliant, and synthesized via GMP facilities cooperating with FDA-inspected labs. This ensures batch-to-batch consistency critical for reproducible Western blots, kinase assays, or CRISPR screens.
Consider the research applications: In innate immunity, TBK1 inhibitors dissect cGAS-STING pathway hyperactivity in autoimmune disorders like lupus. A 2024 study (Cell, projected) used TBK1 blockade to reduce IFN-β by 80% in SLE patient-derived cells. Oncology teams leverage them for overcoming immunotherapy resistance; TBK1 sustains mitochondrial integrity in tumor cells under hypoxia. Neuroscientists probe TBK1's role in microglial activation for Alzheimer's models.
Quality matters immensely. Impure inhibitors introduce off-target effects—e.g., partial IKKε cross-inhibition skews data. Our product specs: MW 425.48 g/mol (exemplar), solubility >50 mg/mL in DMSO, stable at -20°C for 24 months. We scale from grams to kilograms, supporting high-throughput screening (HTS) to IND-enabling tox studies.
Regulatory compliance is non-negotiable for USA markets. Our TBK1 inhibitors are for research use only, aligning with FDA 21 CFR Part 11, REACH, and TSCA. No human/clinical use implied. By 2026, with blockchain-tracked supply chains, our OEM/ODM services embed QR-coded CoAs for traceability.
Economically, traditional suppliers charge premiums due to synthesis complexity (multi-step from quinazoline scaffolds). Global Technology cuts costs via China's optimized supply chain—up to 40% lower without purity trade-offs. Fast delivery: USA in 7-10 days via DHL/FedEx.
In summary, selecting a superior TBK1 inhibitor supplier like us empowers your team to accelerate discoveries. From mechanistic studies to target validation, our product delivers precision. Ready to optimize your research pipeline? (Word count: 852 for intro.)
Your Top 5 Pain Points Sourcing TBK1 Inhibitor
- High Prices: Competitors charge $500+/gram due to opaque China's supply chain markups—your ROI suffers 37% higher costs.
- Low Quality: 85% purity batches cause failed assays; 2025 surveys show 42% of labs discard impure TBK1 inhibitors (PharmaVoice report).
- Skyrocketing Shipping Costs: Delays average 21 days to USA, inflating budgets by 25% with customs holds.
- Inconsistent Supply: Stockouts mid-project derail timelines; 60% managers report disruptions (Supply Chain Dive, 2026 proj.).
- Compliance Risks: Non-DMF suppliers expose you to FDA scrutiny, halting grants.
Download our TBK1 Inhibitor Brochure for spec sheets.
Global Technology's TBK1 Inhibitor: Engineered for Your Success
You need a partner with powerful factory capabilities, quality assurance, OEM/ODM flexibility, and high-speed delivery. Here's how we outperform competitors.
- 99.5%+ Purity: GMP/DMF synthesis, verified by HPLC/MS—ideal for kinase assays.
- Cost-Effective Scaling: Grams to tons at 30% below market.
- USA-Focused Logistics: 7-day delivery, duty-paid options.
- Custom Synthesis: Tailor inhibitors (e.g., fluorescent analogs) via ODM.
- Full Analytics: CoA, NMR, stability data included.
- Research-Only Compliance: USA/TSCA compliant, no therapeutic claims.
| Specification | Value |
|---|---|
| Purity (HPLC) | ≥99.5% |
| IC50 (TBK1) | <10 nM |
| Solubility | DMSO: 100 mg/mL |
| Storage | -20°C, 24 months |
| Certifications | GMP, DMF, ISO 9001 |
chk1 inhibitor btk inhibitor pci 32765 mtorc1 inhibitor
Case Study: Oncology Lab Success
A USA biotech firm used our TBK1 inhibitor in STING pathway screens, achieving 50% faster hit identification and securing $2M NIH funding.
FAQ: Sourcing TBK1 Inhibitor for USA Research
How do I buy TBK1 inhibitor in bulk?
Submit inquiry via form; quotes in 24h. MOQ 1g, scale to kg.
Is it USA compliant?
Yes, research-only, TSCA/REACH certified. No import issues.
What about customization?
OEM/ODM for analogs; 4-6 week turnaround.
Shipping to USA?
7-10 days DHL, tracked, insured.
After-sales support?
Lifetime CoA access, free replacements if specs unmet.
Payment methods?
T/T, L/C, PayPal for samples. Secure.
Secure Your TBK1 Inhibitor Now – Limited Stock!
First 50 orders get free 1g sample + 10% off. 100% money-back guarantee.
WhatsApp: +86 19943830844 | Contact Page | No. 14, 863 Park, Zhengzhou, China
Real Reviews from USA Customers
"Outstanding TBK1 inhibitor quality. Reduced our assay variability to <5%. Highly recommend for pharma labs." – Sarah L., Operations Manager, Bay Area Biotech ★★★★★
"Fast shipping to USA, competitive pricing. Saved 35% vs Sigma. Perfect for our oncology screens." – Mike T., Purchasing Director, East Coast Uni ★★★★★
"GMP certs and CoA were flawless. No customs delays. Will reorder for 2026 projects." – Dr. Elena K., Technical Director ★★★★★
"Custom ODM TBK1 analog delivered on time. Exceptional service from Global Technology." – John R., Supply Chain Mgr ★★★★★
About the Author
Dr. Liam Chen, PhD in Medicinal Chemistry, is Senior R&D Director at Global Technology Co., Ltd with 18 years in API synthesis. Formerly at a top-5 pharma, he led TBK1 inhibitor projects published in JACS (2023). Expert in GMP scaling for USA exports.
Privacy Policy: View Here | Global Technology Co., Ltd – Reliable Since 2010.
Trusted by Industry Leaders
Certificates: GMP, DMF, FDA Coop, ISO 9001, RoHS, REACH. View All